Cargando…
Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study
BACKGROUND: To evaluate the contributions of elevated lipoprotein(a) [Lp(a)] to the risk of coronary heart disease (CHD) in the general Chinese community population according to different lipid profiles. METHODS: We recruited individuals aged over 18 years from the baseline survey of the Cohort Stud...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859748/ https://www.ncbi.nlm.nih.gov/pubmed/33553319 http://dx.doi.org/10.21037/atm-20-3899 |
_version_ | 1783646802567757824 |
---|---|
author | Guo, Chunyue Cao, Han Shan, Guangliang Zhao, Wei Zhang, Han Niu, Kaijun Cui, Ze Tang, Naijun Liu, Kuo Pan, Li Han, Xiaoyan Wang, Zhengfang Meng, Ge Sun, Jixin Shan, Anqi Yan, Yuxiang He, Huijing Xu, Zhiyuan Cao, Yajing Peng, Wenjuan Sun, Yanyan Xie, Yunyi Liu, Xiaohui Li, Bingxiao Wen, Fuyuan Zhang, Ling |
author_facet | Guo, Chunyue Cao, Han Shan, Guangliang Zhao, Wei Zhang, Han Niu, Kaijun Cui, Ze Tang, Naijun Liu, Kuo Pan, Li Han, Xiaoyan Wang, Zhengfang Meng, Ge Sun, Jixin Shan, Anqi Yan, Yuxiang He, Huijing Xu, Zhiyuan Cao, Yajing Peng, Wenjuan Sun, Yanyan Xie, Yunyi Liu, Xiaohui Li, Bingxiao Wen, Fuyuan Zhang, Ling |
author_sort | Guo, Chunyue |
collection | PubMed |
description | BACKGROUND: To evaluate the contributions of elevated lipoprotein(a) [Lp(a)] to the risk of coronary heart disease (CHD) in the general Chinese community population according to different lipid profiles. METHODS: We recruited individuals aged over 18 years from the baseline survey of the Cohort Study on Chronic Disease of Communities Natural Population in Beijing, Tianjin and Hebei (CHCN-BTH) using a stratified, multistage cluster sampling method. Data were collected through questionnaire surveys, anthropometric measures and laboratory tests. Restricted cubic spline (RCS) functions, multivariate logistic regression, sensitivity analyses and stratified analyses were used to evaluate the association between Lp(a) and CHD. RESULTS: A total of 25,343 participants were included, with 1,364 (5.38%) identified as having CHD. Elevated Lp(a) levels were linearly related to an increased risk of CHD (P(overall-association)<0.0001 and P(nonlinear-association)=0.8468). Multivariate logistic regression analysis indicated that subjects with Lp(a) ≥300 mg/L had a higher risk of CHD [OR (95% CI): 1.36 (1.17, 1.57)] than did individuals with Lp(a) <300 mg/L. Compared with individuals with Lp(a) <119.0 mg/L (<50th percentile), the ORs (95% CI) for CHD in the 51st–80th, 81st–95th and >95th percentiles were 1.07 (0.93, 1.23), 1.26 (1.07, 1.50) and 1.68 (1.30, 2.17), respectively (P for trend <0.0001). This association was also found among the subgroup of subjects without dyslipidemia, including those with normal total cholesterol (TC) (<6.2 mmol/L), triglycerides (TG) (<2.3 mmol/L), high-density lipoprotein cholesterol (HDL-C) (≥1.0 mmol/L) and low-density lipoprotein cholesterol (LDL-C) (<4.1 mmol/L). Elevated Lp(a) and dyslipidemia significantly contributed to a higher risk of CHD with synergistic effects. Stratified analyses showed that elevated Lp(a) concentrations were significantly associated with an increased risk of CHD in the subgroups of individuals who were noncurrent drinkers, overweight individuals, individuals with hypertension, individuals who engaged in moderate physical activity, those without diabetes mellitus and individuals in Beijing and Tianjin. CONCLUSIONS: Elevated Lp(a) concentrations were linearly associated with a higher risk of CHD in the general Chinese community population, especially in normolipidemic subjects. Both dyslipidemia and elevated Lp(a) independently or synergistically contributed to the risk of CHD. Our results suggest that more attention should be paid to the levels of Lp(a) in normolipidemic subjects, which may be an early predictor of CHD. |
format | Online Article Text |
id | pubmed-7859748 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-78597482021-02-05 Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study Guo, Chunyue Cao, Han Shan, Guangliang Zhao, Wei Zhang, Han Niu, Kaijun Cui, Ze Tang, Naijun Liu, Kuo Pan, Li Han, Xiaoyan Wang, Zhengfang Meng, Ge Sun, Jixin Shan, Anqi Yan, Yuxiang He, Huijing Xu, Zhiyuan Cao, Yajing Peng, Wenjuan Sun, Yanyan Xie, Yunyi Liu, Xiaohui Li, Bingxiao Wen, Fuyuan Zhang, Ling Ann Transl Med Original Article BACKGROUND: To evaluate the contributions of elevated lipoprotein(a) [Lp(a)] to the risk of coronary heart disease (CHD) in the general Chinese community population according to different lipid profiles. METHODS: We recruited individuals aged over 18 years from the baseline survey of the Cohort Study on Chronic Disease of Communities Natural Population in Beijing, Tianjin and Hebei (CHCN-BTH) using a stratified, multistage cluster sampling method. Data were collected through questionnaire surveys, anthropometric measures and laboratory tests. Restricted cubic spline (RCS) functions, multivariate logistic regression, sensitivity analyses and stratified analyses were used to evaluate the association between Lp(a) and CHD. RESULTS: A total of 25,343 participants were included, with 1,364 (5.38%) identified as having CHD. Elevated Lp(a) levels were linearly related to an increased risk of CHD (P(overall-association)<0.0001 and P(nonlinear-association)=0.8468). Multivariate logistic regression analysis indicated that subjects with Lp(a) ≥300 mg/L had a higher risk of CHD [OR (95% CI): 1.36 (1.17, 1.57)] than did individuals with Lp(a) <300 mg/L. Compared with individuals with Lp(a) <119.0 mg/L (<50th percentile), the ORs (95% CI) for CHD in the 51st–80th, 81st–95th and >95th percentiles were 1.07 (0.93, 1.23), 1.26 (1.07, 1.50) and 1.68 (1.30, 2.17), respectively (P for trend <0.0001). This association was also found among the subgroup of subjects without dyslipidemia, including those with normal total cholesterol (TC) (<6.2 mmol/L), triglycerides (TG) (<2.3 mmol/L), high-density lipoprotein cholesterol (HDL-C) (≥1.0 mmol/L) and low-density lipoprotein cholesterol (LDL-C) (<4.1 mmol/L). Elevated Lp(a) and dyslipidemia significantly contributed to a higher risk of CHD with synergistic effects. Stratified analyses showed that elevated Lp(a) concentrations were significantly associated with an increased risk of CHD in the subgroups of individuals who were noncurrent drinkers, overweight individuals, individuals with hypertension, individuals who engaged in moderate physical activity, those without diabetes mellitus and individuals in Beijing and Tianjin. CONCLUSIONS: Elevated Lp(a) concentrations were linearly associated with a higher risk of CHD in the general Chinese community population, especially in normolipidemic subjects. Both dyslipidemia and elevated Lp(a) independently or synergistically contributed to the risk of CHD. Our results suggest that more attention should be paid to the levels of Lp(a) in normolipidemic subjects, which may be an early predictor of CHD. AME Publishing Company 2021-01 /pmc/articles/PMC7859748/ /pubmed/33553319 http://dx.doi.org/10.21037/atm-20-3899 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Guo, Chunyue Cao, Han Shan, Guangliang Zhao, Wei Zhang, Han Niu, Kaijun Cui, Ze Tang, Naijun Liu, Kuo Pan, Li Han, Xiaoyan Wang, Zhengfang Meng, Ge Sun, Jixin Shan, Anqi Yan, Yuxiang He, Huijing Xu, Zhiyuan Cao, Yajing Peng, Wenjuan Sun, Yanyan Xie, Yunyi Liu, Xiaohui Li, Bingxiao Wen, Fuyuan Zhang, Ling Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study |
title | Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study |
title_full | Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study |
title_fullStr | Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study |
title_full_unstemmed | Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study |
title_short | Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study |
title_sort | elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general chinese community population: the chcn-bth study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859748/ https://www.ncbi.nlm.nih.gov/pubmed/33553319 http://dx.doi.org/10.21037/atm-20-3899 |
work_keys_str_mv | AT guochunyue elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT caohan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT shanguangliang elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT zhaowei elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT zhanghan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT niukaijun elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT cuize elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT tangnaijun elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT liukuo elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT panli elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT hanxiaoyan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT wangzhengfang elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT mengge elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT sunjixin elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT shananqi elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT yanyuxiang elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT hehuijing elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT xuzhiyuan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT caoyajing elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT pengwenjuan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT sunyanyan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT xieyunyi elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT liuxiaohui elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT libingxiao elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT wenfuyuan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy AT zhangling elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy |